Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DORM - US2582781009 - Common Stock

126.52 USD
-0.17 (-0.13%)
Last: 12/19/2025, 8:00:01 PM
126.52 USD
0 (0%)
After Hours: 12/19/2025, 8:00:01 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to DORM. DORM was compared to 81 industry peers in the Automobile Components industry. DORM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DORM is not valued too expensively and it also shows a decent growth rate. With these ratings, DORM could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
DORM had a positive operating cash flow in the past year.
In the past 5 years DORM has always been profitable.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

DORM has a Return On Assets of 9.70%. This is amongst the best in the industry. DORM outperforms 95.12% of its industry peers.
DORM's Return On Equity of 16.70% is amongst the best of the industry. DORM outperforms 95.12% of its industry peers.
With an excellent Return On Invested Capital value of 13.16%, DORM belongs to the best of the industry, outperforming 93.90% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 8.55%.
The 3 year average ROIC (9.34%) for DORM is below the current ROIC(13.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROIC 13.16%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM has a better Profit Margin (11.65%) than 98.78% of its industry peers.
DORM's Profit Margin has improved in the last couple of years.
DORM has a Operating Margin of 16.71%. This is amongst the best in the industry. DORM outperforms 98.78% of its industry peers.
In the last couple of years the Operating Margin of DORM has grown nicely.
Looking at the Gross Margin, with a value of 41.88%, DORM belongs to the top of the industry, outperforming 92.68% of the companies in the same industry.
In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
Compared to 1 year ago, DORM has less shares outstanding
DORM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 4.68. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
DORM has a Altman-Z score of 4.68. This is amongst the best in the industry. DORM outperforms 85.37% of its industry peers.
The Debt to FCF ratio of DORM is 4.33, which is a neutral value as it means it would take DORM, 4.33 years of fcf income to pay off all of its debts.
DORM has a Debt to FCF ratio of 4.33. This is amongst the best in the industry. DORM outperforms 82.93% of its industry peers.
DORM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
DORM has a better Debt to Equity ratio (0.28) than 80.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Altman-Z 4.68
ROIC/WACC1.53
WACC8.6%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.94 indicates that DORM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.94, DORM belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
DORM has a Quick Ratio of 1.19. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
DORM's Quick ratio of 1.19 is fine compared to the rest of the industry. DORM outperforms 73.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.19
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.71% over the past year.
DORM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.83% yearly.
The Revenue has been growing slightly by 7.94% in the past year.
DORM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%

3.2 Future

Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 6.18% on average per year.
EPS Next Y26.18%
EPS Next 2Y16.16%
EPS Next 3Y14.91%
EPS Next 5Y7.8%
Revenue Next Year8.33%
Revenue Next 2Y6.78%
Revenue Next 3Y6.27%
Revenue Next 5Y6.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.22, which indicates a correct valuation of DORM.
Compared to the rest of the industry, the Price/Earnings ratio of DORM indicates a somewhat cheap valuation: DORM is cheaper than 63.41% of the companies listed in the same industry.
DORM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.38.
Based on the Price/Forward Earnings ratio of 13.13, the valuation of DORM can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DORM is on the same level as its industry peers.
DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.83.
Industry RankSector Rank
PE 14.22
Fwd PE 13.13
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

DORM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. DORM is more expensive than 60.98% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DORM indicates a slightly more expensive valuation: DORM is more expensive than 63.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.76
EV/EBITDA 10.38
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
DORM's earnings are expected to grow with 14.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)0.65
EPS Next 2Y16.16%
EPS Next 3Y14.91%

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield 0%

DORMAN PRODUCTS INC

NASDAQ:DORM (12/19/2025, 8:00:01 PM)

After market: 126.52 0 (0%)

126.52

-0.17 (-0.13%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-27 2025-10-27/amc
Earnings (Next)02-24 2026-02-24/bmo
Inst Owners86.95%
Inst Owner Change1.22%
Ins Owners13.6%
Ins Owner Change-1.14%
Market Cap3.87B
Revenue(TTM)2.13B
Net Income(TTM)247.63M
Analysts82.86
Price Target176.97 (39.88%)
Short Float %4.6%
Short Ratio5.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.92%
Max EPS beat(2)11.58%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.92%
Max EPS beat(4)36.11%
EPS beat(8)8
Avg EPS beat(8)23.63%
EPS beat(12)8
Avg EPS beat(12)10.09%
EPS beat(16)9
Avg EPS beat(16)7.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)3
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)0.21%
PT rev (1m)3.2%
PT rev (3m)6.22%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)-1.2%
EPS NY rev (1m)0.06%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
Industry RankSector Rank
PE 14.22
Fwd PE 13.13
P/S 1.82
P/FCF 36.76
P/OCF 27.04
P/B 2.61
P/tB 4.98
EV/EBITDA 10.38
EPS(TTM)8.9
EY7.03%
EPS(NY)9.63
Fwd EY7.61%
FCF(TTM)3.44
FCFY2.72%
OCF(TTM)4.68
OCFY3.7%
SpS69.57
BVpS48.51
TBVpS25.41
PEG (NY)0.54
PEG (5Y)0.65
Graham Number98.56
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROCE 17.45%
ROIC 13.16%
ROICexc 13.53%
ROICexgc 21.03%
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
FCFM 4.95%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Debt/EBITDA 1.02
Cap/Depr 67.78%
Cap/Sales 1.78%
Interest Coverage 11.7
Cash Conversion 34.78%
Profit Quality 42.47%
Current Ratio 2.94
Quick Ratio 1.19
Altman-Z 4.68
F-Score7
WACC8.6%
ROIC/WACC1.53
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
EPS Next Y26.18%
EPS Next 2Y16.16%
EPS Next 3Y14.91%
EPS Next 5Y7.8%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%
Revenue Next Year8.33%
Revenue Next 2Y6.78%
Revenue Next 3Y6.27%
Revenue Next 5Y6.18%
EBIT growth 1Y25.27%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year38.49%
EBIT Next 3Y15.9%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y-11.46%
OCF growth 3Y32.07%
OCF growth 5Y19.38%

DORMAN PRODUCTS INC / DORM FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 7 / 10 to DORM.


What is the valuation status of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


What is the financial health of DORMAN PRODUCTS INC (DORM) stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 8 / 10.


Can you provide the dividend sustainability for DORM stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.